Key Takeaways:
- Sanome is a London-based MedTech startup addressing the
enormous gap in healthcare with demand massively outweighing
supply. - Sanome is transforming the ability to translate hospital data into
clinically actionable insights to enable early detection and prevention
of deteriorations. - Using advanced AI/ML, Sanome is building a clinical Co-pilot. It is
initially predicting hospital acquired infections
The UK’s thriving Healthtech sector is making remarkable strides in healthcare innovation, particularly when leveraging the advances in AI. A standout player in this arena is Sanome, a MedTech startup with a vision to revolutionize the field of clinical decision making. Located in the heart of London, this company is changing the healthcare landscape by creating technology that acts as an early warning system (EWS) for health deterioration detection and prevention.
By leveraging the enormous amount of hospital data, Sanome translates multimodal data streams into high value clinical insights to support clinical decision-making to help clinicians identify changes to a patient’s health earlier – a clinical co-pilot. Their mission aligns with the globally acknowledged need for AI/ML to tackle the biggest health challenges of our generation.
What sets Sanome apart lies both in their technology and approach – combining a multimodal, biomedical AI framework with building deep partnerships with selected forward-thinking hospitals Sanome co-design and validate powerful clinical insights. These are regulated as a Softwareas-a-Medical Device (SaMD) and integrated into existing hospital IT systems to simplify clinical adoption and support overstretched clinicians with identifying patient deteriorations earlier. Sanome’s clinical co-pilot, consequently, will have an enormous impact in clinical settings by cost saving, improving patient outcomes and reducing staff burnout.
Sanome, fronted by industry-expert Benedikt von Thungen, exemplifies the potential for growth and innovation in the UK’s MedTech sector. The company’s vision, translating unused data into clinically actionable insights, seems promising in transforming global healthcare practices, particularly due to the massive digital explosion of healthcare data.
The future undoubtedly holds exciting possibilities for Sanome and the whole industry. With continuous advancements in the field, companies like Sanome are poised to refine and redefine the healthcare paradigm through more effective, accessible, and personalised deterioration detection.
Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.
